Format

Send to

Choose Destination
J Med Ethics. 2017 Dec;43(12):865-866. doi: 10.1136/medethics-2015-103248. Epub 2017 Mar 23.

Distress, disease, desire: perspectives on the medicalisation of premature ejaculation.

Author information

1
Institute for History, Theory and Ethics in Medicine, RWTH Aachen University Hospital, Aachen, Germany.
2
Malmö University, Malmö, Sweden.

Abstract

The discovery that certain selective serotonin reuptake inhibitors delay ejaculation and the later development and approval of dapoxetine as an on-demand treatment option has led to a dramatic increase in medical interest in premature ejaculation. This paper analyses the diagnostic criteria and the discussion within the medical community about suitable treatments against the backdrop of theories of science, sex and gender. Our conclusion is that the diagnosis itself and the suggested treatments contribute to normative models of sexual conduct and therefore reinforce the norms that cause patients' distress over ejaculating 'too soon'.

KEYWORDS:

Concept of Health; Drugs and Drug Industry; Sexuality/Gender

PMID:
28341756
DOI:
10.1136/medethics-2015-103248
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center